Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription

Developmental Biology

Volumn 179, Issue 2, 1996, Pages 402-411

  Kirshenbaum, Lorrie A ^a   Abdellatif, Maha ^b   Chakraborty, Subendu ^c   Schneider, Michael D ^b,c  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b Molecular Cardiology Unit   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; HEART MUSCLE CELL; HEART VENTRICLE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

ADENOVIRIDAE; ANIMALIA; MAMMALIA;

EID: 0030296944     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1996.0270     Document Type: Article

References (52)

1. Abdellatif, M., MacLellan, W. R., and Schneider, M. D. (1994). p21 Ras as a governor of global gene expression. J. Biol. Chem. 269, 15423-15426.
2. Bacus, J. W., and Grace, L. J. (1987). Optical microscope system for standardized cell measurements and analyses. Appl. Optics 26, 3280-3293.
3. Bader, D., Masaki, T., and Fischman, D. A. (1982). Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo. J. Cell Biol. 95, 763-770.
4. Brand, T., MacLellan, W. R., and Schneider, M. D. (1993). A dominant-negative receptor for type-beta transforming growth factors created by deletion of the kinase domain. J. Biol. Chem. 268, 11500-11503.
5. Caruso, M., Martelli, F., Giordano, A., and Felsani, A. (1993). Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene 8, 267-278.
6. Chiou, S. K., Tseng, C. C., Rao, L., and White, E. (1994). Functional complementation of the adenovirus E1B 19-kilodalton protein within the inhibition of apoptosis in infected cells. J. Virol. 68, 6553-6566.
7. Claycomb, W. C., and DiNardo, P. (1995). "Cardiac Growth and Regeneration." N. Y. Acad. Sci., New York.
8. Cress, W. D., Johnson, D. G., and Nevins, J. R. (1993). A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus-E4. Mol. Cell. Biol. 13, 6314-6325.
9. Croissant, J. D., Kim, J. H., Eichele, G., Goering, L., Lough, J., Prywes, R., and Schwartz, R. J. (1996). Avian serum response factor expression restricted primarily to muscle cell lineages is required for α-actin gene transcription. Dev. Biol. 177, in press.
10. 1 cyclin-dependent kinase activity. Genes Dev. 9, 2873-2887.
11. Dorsman, J. C., Hagmeyer, B. M., Veenstra, J., Elfferich, P., Nabben, N., Zantema, A., and van der Eb, A. J. (1995). The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains. J. Virol. 69, 2962-2967.
12. Field, L. J. (1988). Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science 239, 1029-1033.
13. Field, S. J., Tsai, F. Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., and Greenberg, M. E. (1996). E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561.
14. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
15. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadal-Ginard, B. (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
16. Johnson, D. G., Schwarz, J. K., Cress, W. D., and Nevins, J. R. (1993). Expression of transcription factor E2F1 induces quiescent cells to enter S-phase. Nature 365, 349-352.
17. Katz, E. B., Steinhelper, M. E., Delcarpio, J. B., Daud, A. I., Claycomb, W. C., and Field, L. J. (1992). Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am. J. Physiol. 262, H1867-H1876.
18. Kim, K. K., Soonpaa, M. H., Daud, A. I., Koh, G. Y., Kim, J. S., and Field, L. J. (1994). Tumor suppressor gene expression during normal and pathological myocardial growth. J. Biol. Chem. 269, 22607-22613.
19. Kirshenbaum, L. A., MacLellan, W. R., Mazur, W., French, B. A., and Schneider, M. D. (1993). Highly efficient gene transfer to adult rat ventricular myocytes by recombinant adenovirus. J. Clin. Invest. 92, 381-387.
20. Kirshenbaum, L. A., and Schneider, M. D. (1995). Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein-and p300-binding domains. J. Biol. Chem. 270, 7791-7794.
21. Krek, W., Xu, G. F., and Livingston, D. M. (1995). Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83, 1149-1158.
22. Liu, Y., and Kitsis, R. N. (1996). Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J. Cell Biol. 133, 325-334.
23. MacLellan, W. R., Lee, T. C., Schwartz, R. J., and Schneider, M. D. (1994). Transforming growth factor-beta response elements of the skeletal alpha-actin gene: Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. J. Biol. Chem. 269, 16754-16760.
24. Massagué, J., Cheifetz, S., Endo, T., and Nadal-Ginard, B. (1986). Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83, 8206-8210.
25. Moran, E. (1994). Mammalian cell growth controls reflected through protein interactions with the adenovirus E1A gene products. Semin. Virol. 5, 327-340.
26. Moran, E., Grodzicker, T., Roberts, R. J., Mathews, M. B., and Zerler, B. (1986). Lytic and transforming functions of individual products of the adenovirus E1A gene. Mol. Cell. Biol. 57, 765-775.
27. Moss, J. B., McQuinn, T. C., and Schwartz, R. J. (1994). The avian cardiac alpha-actin promoter is regulated through a pair of complex elements composed of E boxes and serum response elements that bind both positive-and negative-acting factors. J. Biol. Chem. 269, 12731-12740.
28. Nevins, J. R. (1992). E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-429.
29. Olson, E. N. (1993). Regulation of muscle transcription by the MyoD family - The heart of the matter. Circ. Res. 72, 1-6.
30. Olson, E. N., and Klein, W. H. (1994). bHLH factors in muscle development - dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8, 1-8.
31. Parker, T. G., Packer, S. E., and Schneider, M. D. (1990). Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85, 507-514.
32. Payne, P. A., Olson, E. N., Hsiau, P., Roberts, R., Perryman, M. B., and Schneider, M. D. (1987). An activated c-Ha-ras allele blocks the induction of muscle specific genes whose expression is contingent on mitogen withdrawal. Proc. Natl. Acad. Sci. USA 84, 8956-8960.
33. Qin, X. Q., Livingston, D. M., Ewen, M., Sellers, W. R., Arany, Z., and Kaelin, W. G. (1995). The transcription factor E2F-1 is a downstream target of Rb action. Mol. Cell. Biol. 15, 742-755.
34. Qin, X. Q., Livingston, D. M., Kaelin, W. G., and Adams, P. D. (1994). Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91, 10918-10922.
35. Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R. A. (1995). E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92, 2403-2407.
36. Sartorelli, V., Hong, N. A., Bishopric, N. H., and Kedes, L. (1992). Myocardial activation of the human cardiac α-actin promoter by helix-loop-helix proteins. Proc. Natl. Acad. Sci. USA 89, 4047-4051.
37. Schneider, J. W., Gu, W., Zhu, L., Mahdavi, V., and Nadal-Ginard, B. (1994). Reversal of terminal differentiation mediated by p107 in Rb(-/-) muscle cells. Science 264, 1467-1471.
38. Schwarz, J. K., Bassing, C. H., Kovesdi, I., Datto, M. B., Blazing, M., George, S., Wang, X. F., and Nevins, J. R. (1995). Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc. Natl. Acad. Sci. USA 92, 483-487.
39. Shan, B., and Lee, W. H. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166-8173.
40. Sharp, W. W., Terracio, L., Borg, T. K., and Samarel, A. M. (1993). Contractile activity modulates actin synthesis and turnover in cultured neonatal rat heart cells. Circ. Res. 73, 172-183.
41. Shin, E. K., Shin, A., Paulding, C., Schaffhausen, B., and Yee, A. S. (1995). Multiple changes in E2F function and regulation occur upon muscle differentiation. Mol. Cell. Biol. 15, 2252-2262.
42. Skalli, O., Gabbiani, G., Babai, F., Seemayer, T. A., Pizzolato, G., and Schurch, W. (1988). Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas. Am. J. Pathol. 130, 515-31.
43. Tam, S. K. C., Gu, W., Mahdavi, V., and Nadal-Ginard, B. (1995). Cardiac myocyte terminal differentiation. In "Cardiac Growth and Regeneration (W. C. Claycomb and P. DiNardo, Eds.), pp. 72-79. N. Y. Acad. Sci., New York.
44. Thorburn, A., Thorburn, J., Chen, S. Y., Powers, S., Shubeita, H. E., Feramisco, J. R., and Chien, K. R. (1993). HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle hypertrophy. J. Biol. Chem. 268, 2244-2249.
45. Vairo, G., Livingston, D. M., and Ginsburg, D. (1995). Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9, 869-881.
46. Wang, H.-G. H., Rikitake, Y., Carter, M. C., Yaciuk, P., Abraham, S. E., Zerler, B., and Moran, E. (1993). Identification of specific adenovirus-E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67, 476-488.
47. Wang, J., Helin, K., Jin, P., and Nadal-Ginard, B. (1995). Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1. Cell Growth Differ. 6, 1299-1306.
48. Weinberg, R. A. (1996). E2F and cell proliferation: A world turned upside down. Cell 85, 457-459.
49. Weintraub, S. J., Prater, C. A., and Dean, D. C. (1992). Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358, 259-261.
50. Wu, C. L., Zukerberg, L. R., Ngwu, C., Harlow, E., and Lees, J. A. (1995). In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15, 2536-2546.
51. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N. J. (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548.
52. Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M. E., Livingston, D. M., Dyson, N., and Harlow, E. (1993). Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7, 1111-1125.